Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Chemosphere ; 94: 199-202, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24083901

RESUMEN

Solid-phase extraction (SPE) of nine polychlorinated biphenyls (PCBs) from transformer oil samples was evaluated using octadecyl (CI8)-bonded porous silica. The efficiency of SPE of these PCBs was compared with those obtained by solvent extraction with DMSO and hexane. Average recoveries exceeding 95% for these PCBs were obtained via the SPE method using small cartridges containing 100mg of 40 pm CI8-bonded porous silica. The average recovery by solvent extraction with DMSO and hexane exceeded 83%. It was concluded that the recoveries and precision for the solvent extraction of PCBs were poorer than those for the SPE.


Asunto(s)
Fraccionamiento Químico/métodos , Residuos Electrónicos , Bifenilos Policlorados/análisis , Electrónica , Aceites/química , Dióxido de Silicio , Extracción en Fase Sólida/métodos , Solventes
4.
J Pediatr Ophthalmol Strabismus ; 38(3): 131-5; quiz 172-3, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11386644

RESUMEN

PURPOSE: To evaluate the efficacy of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus. METHODS: Sixteen patients with restrictive strabismus resulting from trauma, retinal detachment surgery, and multiple squint surgeries were randomized to either a mitomycin group (8 patients) or a control group (8 patients). Mitomycin C (0.2 mg/mL) was applied intraoperatively for 5 minutes after release of adhesions. Range of passive ductions was scored for comparison. Postoperative follow-up ranged from 3-18 months. RESULTS: Compared to controls, the mitomycin C group had better range of passive ductions. There were no complications related to the cornea, intraocular pressure, uveitis, or muscle disinsertion in the mitomycin C group. CONCLUSION: Intraoperative application of mitomycin C (0.2 mg/mL for 5 minutes) is a safe and effective adjunct to surgery in the treatment of restrictive strabismus.


Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Mitomicina/uso terapéutico , Complicaciones Posoperatorias/tratamiento farmacológico , Estrabismo/cirugía , Adolescente , Adulto , Quimioterapia Adyuvante , Niño , Método Doble Ciego , Femenino , Fibroblastos/efectos de los fármacos , Estudios de Seguimiento , Humanos , Masculino , Estudios Prospectivos , Recurrencia , Adherencias Tisulares/prevención & control , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...